Molecular Therapy
Volume 12, Issue 3, September 2005, Pages 555-561
Journal home page for Molecular Therapy

Article
Toward a Gene Therapy for Dominant Disease: Validation of an RNA Interference-Based Mutation-Independent Approach

https://doi.org/10.1016/j.ymthe.2005.03.028Get rights and content
Under a Creative Commons license
open archive

Abstract

The intragenic heterogeneity encountered in many dominant disease-causing genes represents a significant challenge with respect to development of economically viable therapeutics. For example, 25% of autosomal dominant retinitis pigmentosa is caused by over 100 different mutations within the gene encoding rhodopsin, each of which could require a unique gene therapy. We describe here an RNA interference (RNAi)-based mutation-independent approach, targeting as an example murine rhodopsin. Native transcripts are suppressed by a single RNAi molecular species, whereas transcripts from replacement genes engineered at degenerate third-codon wobble positions are resistant to suppression. We demonstrate suppression of murine rhodopsin transcript by up to 90% with full concomitant expression of replacement transcript and establish the validity of this approach in cell culture, retinal explants, and mouse liver in vivo.

Keywords

gene therapy
RNA interference
small interfering RNA
rhodopsin
genetic suppression

Cited by (0)